Answers are grounded in this paper and cite their sources.
Autoimmune-inflammatory myopathy-related interstitial lung disease (AIM-ILD) encompasses a heterogeneous spectrum of pulmonary involvement, with patterns ranging from predominantly inflammatory to clearly fibrosing, and is characterized by a highly variable clinical course and prognosis.1,2
No takes yet. Share an insight, caveat, or question.
Monteleone et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: